Investsud

TrustUp is a platform that connects homeowners with verified home improvement contractors. It operates as a marketplace for construction and renovation services, helping users find reliable professionals for various home projects. TrustUp focuses on ensuring quality by providing a guarantee for the work completed, enabling customers to access consistent and effective professional services. By streamlining the process of hiring home service providers, TrustUp aims to enhance the overall experience for homeowners seeking trustworthy assistance with their home improvement needs.

Brenus Pharma is focused on developing cell-based immunotherapies aimed at treating solid tumors. The company utilizes an allogeneic platform to create anti-cancer cell vaccines, which leverage the patient's immune system to combat cancer and reduce the risk of treatment resistance. Their approach emphasizes generating multiple candidate therapies efficiently, allowing for cost-effective scaling and integration with existing treatment standards. With a strong intellectual property portfolio and a team of experienced professionals, including renowned oncologists, Brenus Pharma seeks to educate the immune system to recognize and respond to tumor-associated and tumor-specific antigens, enhancing the effectiveness of chemotherapy and radiotherapy in cancer care.

Myocene is a sports technology company based in Liège that specializes in developing innovative devices to measure muscle fatigue and performance. Utilizing patented algorithms and artificial intelligence, Myocene's devices enable athletes to easily assess their muscle fatigue, endurance, and stamina. By providing precise measurements, the company's technology aims to enhance athletic performance and support athletes in optimizing their training regimens.

AbolerIS Pharma is a biotechnology company based in Nantes, France, focused on developing immune-modulators for the treatment of transplant rejection, graft-versus-host disease, and autoimmune diseases. Established in 2019, the company employs a unique therapeutic approach that aims to induce immune tolerance while preserving beneficial immune responses in various inflammatory and degenerative conditions. Its product portfolio includes Anti-CD45RC, a monoclonal antibody designed to deplete effector T cells, and IL-34, a cytokine that promotes the induction of tolerogenic macrophages and regulatory T cells. AbolerIS Pharma's innovative strategies enable researchers to advance novel drug development in areas with significant unmet medical needs.

Cikisi is a company that specializes in Web Intelligence, focusing on the collection, searching, and filtering of relevant online information for businesses and organizations. It develops and commercializes Cikisi WMT, a Web Intelligence Solution designed to provide real-time, tailored market insights. By leveraging artificial intelligence, the software streamlines the processes of collecting, processing, and disseminating pertinent data. This enables clients to make informed decisions more quickly, enhancing their ability to capitalize on valuable web information for their development and growth.

Curvo is an investment application focused on enhancing the financial well-being of young Europeans through index investing. The platform allows users to quickly create an account and invest in a diversified portfolio of index funds tailored to their individual goals and preferences. With a minimum investment of €50, Curvo aims to make investing accessible to a broad audience, simplifying the complexities associated with effective financial management. The application offers a user-friendly and secure environment for individuals to strengthen their savings and prepare for their financial futures.

DeuterOncology is a preclinical-stage biotechnology company dedicated to developing innovative cancer therapies. The company's primary focus is on a first-in-class dual MET and RAS pathway inhibitor, currently under investigation as a targeted treatment for lung cancer. This lead compound aims to enhance oncology treatment outcomes and may have broader applications when combined with standard of care and other targeted agents. By optimizing the therapeutic approach to cancer, DeuterOncology seeks to improve the effectiveness of treatment options available to medical professionals and ultimately benefit cancer patients.

Eclo is an urban farming company that specializes in producing exotic mushrooms by utilizing waste materials, specifically spent beer grain. By recycling this byproduct, Eclo not only contributes to sustainable practices but also provides customers with organic mushrooms and baby herbs. The company's focus on innovative waste management in agriculture highlights its commitment to environmental responsibility while meeting the growing demand for high-quality, organic produce.